ArticleCureus2015

Extended Survival after Complete Pathological Response in Metastatic Pancreatic Ductal Adenocarcinoma Following Induction Chemotherapy, Chemoradiotherapy, and a Novel Immunotherapy Agent, IMM-101.

Mafalda Costa Neves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.